Background: Endogenous opioids released from CD4+T cells are increased in inflammatory bowel disease patients (IBD) and pre-clinical models of IBD, and have an important analgesic effect. We have shown that endogenous opioids in supernatant from cDSS mice have an antinociceptive action on dorsal root ganglia (DRG) neurons that is mediated by δ (DOR) and μ (MOR) opioid receptors. We also found that acute application of opioids for minutes had an unexpectedly sustained analgesic effect but the mechanism was unclear. Aims: We hypothesized that endogenous opioids have a sustained antinociceptive effect on nociceptors via endosomal signaling. Methods: Chronic colitis was induced with 2% dextran sulfate sodium (DSS; three cycles: 5 days of DSS/5 days of water) in C57BL/6 mice and colonic supernatants were collected. DRG neurons were exposed to control or cDSS supernatants (1h), or opioid agonists (10nM, 15min); DAMGO (MOR-selective) or DADLE (DORselective). We recorded changes in rheobase (minimum current to fire action potential) by perforated patch-clamp, immediately after washout of drugs (T0) or 30 min later (T30). We used Förster resonance energy transfer (FRET) biosensors to examine signaling (protein kinase C; PKC and extracellular signal-regulated kinase; ERK) in subcellular compartments mediated by DOR agonists: DADLE and SNC80 (100nM). DRG neurons from DOR-eGFP mice were nucleofected with FRET sensors. Neurons were pre-treated with dynamin GTPase (50 μM dyngo4a) or clathrin inhibitor, (15 μM pistop2) for 30 min prior to agonists. One or Two way ANOVA and post hoc Tukey's tests were used to analyze the data. Results: Supernatant from cDSS mice had a sustained antinociceptive effect on neuronal excitability (increased rheobase 39.6%, p<0.05 %). Similarly, DADLE increased the rheobase at time 0 and T30 compared to control (27.4% and 38.2%, p<0.01) whereas DAMGO had no sustained effect. The clathrin inhibitor Pistop2, which inhibits receptor endocytosis, blocked the sustained antinociceptive effect (T30) of cDSS supernatant and DADLE, but did not affect the immediate response
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